12-16 Patients with stage IIB/C and stage III melanoma, despite radical surgery, have a high risk for relapse within 5 years of their initial treatment. Historically, interferon-alpha-2B has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback